Mode
Text Size
Log in / Sign up

Mometasone Furoate

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Mometasone Furoate

13 trials tracked of Mometasone Furoate: 9 in phase 3 or 4 and 2 with published results. The most-cited published study has 121 citations.

13Trials tracked
9Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 9 Phase 2 4
  1. Phase 3 Effect of Mepolizumab in Severe Bilateral Nasal Polyps Completed · 121 cited
  2. Phase 3 A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma Completed · 50 cited
  3. Phase 3 Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013) Completed
  4. Phase 3 Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001) Completed
  5. Phase 3 Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) Completed
  6. Phase 3 A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis Completed
Show 7 more trials
  1. Phase 3 Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ Completed
  2. Phase 3 A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1) Completed
  3. Phase 3 Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED) Completed
  4. Phase 2 Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma Completed
  5. Phase 2 Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease Completed
  6. Phase 2 Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma Completed
  7. Phase 2 Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.